185 related articles for article (PubMed ID: 17886559)
1. Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status.
Clark AJ; Dos Santos WG; McCready J; Chen MY; Van Meter TE; Ware JL; Wolber SB; Fillmore H; Broaddus WC
J Neurosurg; 2007 Sep; 107(3):586-92. PubMed ID: 17886559
[TBL] [Abstract][Full Text] [Related]
2. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.
Chidambaram A; Fillmore HL; Van Meter TE; Dumur CI; Broaddus WC
J Neurosurg; 2012 Apr; 116(4):843-53. PubMed ID: 22313360
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53 gene mutations in human glioma cell lines.
Koga H; Zhang S; Washiyama K; Ichikawa T; Onda K; Kumanishi T
Noshuyo Byori; 1996 Apr; 13(1):1-10. PubMed ID: 8916120
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors.
Dennis SL; Manji SS; Carrington DP; Scarcella DL; Ashley DM; Smith PJ; Algar EM
Int J Cancer; 2002 Feb; 97(5):713-5. PubMed ID: 11807803
[TBL] [Abstract][Full Text] [Related]
5. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
7. Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary.
Makrigiannakis A; Amin K; Coukos G; Tilly JL; Coutifaris C
J Clin Endocrinol Metab; 2000 Jan; 85(1):449-59. PubMed ID: 10634423
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of p53 dependent apoptosis in glia-derived tumors of the brain].
Kaczmarczyk R; Słodziński H; Trojanowski T; Polz-Dacewicz M
Neurol Neurochir Pol; 2001; 35 Suppl 5():30-3. PubMed ID: 11935677
[TBL] [Abstract][Full Text] [Related]
9. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
10. Expression of WT1 protein and correlation with cellular proliferation in glial tumors.
Hashiba T; Izumoto S; Kagawa N; Suzuki T; Hashimoto N; Maruno M; Yoshimine T
Neurol Med Chir (Tokyo); 2007 Apr; 47(4):165-70; discussion 170. PubMed ID: 17457020
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.
Iwadate Y; Fujimoto S; Tagawa M; Namba H; Sueyoshi K; Hirose M; Sakiyama S
Int J Cancer; 1996 Jun; 69(3):236-40. PubMed ID: 8682593
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 and prognosis in children with malignant gliomas.
Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R;
N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530
[TBL] [Abstract][Full Text] [Related]
13. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
14. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
[TBL] [Abstract][Full Text] [Related]
15. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
16. [Mutations of p53 gene in 41 cases of human brain gliomas].
Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
[TBL] [Abstract][Full Text] [Related]
17. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
18. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
19. WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.
Koesters R; Linnebacher M; Coy JF; Germann A; Schwitalle Y; Findeisen P; von Knebel Doeberitz M
Int J Cancer; 2004 Apr; 109(3):385-92. PubMed ID: 14961577
[TBL] [Abstract][Full Text] [Related]
20. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
